Prospective, Multiconfiguration Study to Assess Functional Performance of Primary Total Knee Arthroplasty System
NCT ID: NCT01746524
Last Updated: 2019-04-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1138 participants
OBSERVATIONAL
2012-11-01
2018-03-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The primary objective of this study is to evaluate the pre-operative (approximately -90 to -1 day before surgery) to minimum one year (approximately 304 to 668 days) postoperative functional performance improvement for the Attune™ primary, cemented TKA system as measured by the activities of daily living (ADL)subscore of the Knee Osteoarthritis Outcomes Score (KOOS)questionnaire (KOOS-ADL sub-score). This will be carried out for all four implant configurations: cruciate retaining fixed bearing (Attune™ CR FB), cruciate retaining rotating platform (Attune™ CR RP), posterior stabilized fixed bearing (Attune™ PS FB), and posterior stabilized rotating platform (Attune™ PS RP).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
ATTUNE® Revision- Complex Primary in Total Knee Arthroplasty Population
NCT03153449
Evaluation of Post-Operative Recovery in ATTUNE® Total Knee Arthroplasty
NCT02339610
ATTUNE Revision System in the Revision Total Knee Arthroplasty Population
NCT03153475
DePuy Attune Total Knee Arthroplasty RSA Study
NCT02103504
The ATtune Knee Outcome Study
NCT04247672
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Approximately 20 study sites, worldwide, will enroll 1040 subjects (1040 knees). Each study is expected to enroll approximately 52 subjects (approximately 52 knees). An additional 10 subjects per site may be recruited at sites which have Sub-Investigators participating in the study. Cohort reallocation is permitted. There will be no control group. One thousand and forty (1040)Subjects will be stratified into 4 subgroups of 260: cruciate retaining fixed bearing(CR FB), posterior stabilized fixed bearing (PS FB), cruciate retaining rotating platform (CR RP), and posterior stabilized rotating platform (PS RP). Treatment assignment in this study is not randomized.
Each site will only enroll patients in one of the four knee configuration sub-groups most commonly used as their standard of care.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
CR FB
Subjects receiving Cruciate Retaining Fixed Bearing configuration of ATTUNE Primary Knee Implant
ATTUNE Primary Total Knee Arthroplasty
Patients will undergo a primary, cemented total knee replacement using one of the four configurations of the Attune knee (CR FB, PS FB, CR RP, PS RP).
PS FB
Subjects receiving Posterior Stabilized Fixed Bearing configuration of ATTUNE Primary Knee Implant
ATTUNE Primary Total Knee Arthroplasty
Patients will undergo a primary, cemented total knee replacement using one of the four configurations of the Attune knee (CR FB, PS FB, CR RP, PS RP).
CR RP
Subjects receiving Cruciate Retaining Rotating Platform configuration of ATTUNE Primary Knee Implant
ATTUNE Primary Total Knee Arthroplasty
Patients will undergo a primary, cemented total knee replacement using one of the four configurations of the Attune knee (CR FB, PS FB, CR RP, PS RP).
PS RP
Subjects receiving Posterior Stabilized Rotating Platform configuration of ATTUNE Primary Knee Implant
ATTUNE Primary Total Knee Arthroplasty
Patients will undergo a primary, cemented total knee replacement using one of the four configurations of the Attune knee (CR FB, PS FB, CR RP, PS RP).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ATTUNE Primary Total Knee Arthroplasty
Patients will undergo a primary, cemented total knee replacement using one of the four configurations of the Attune knee (CR FB, PS FB, CR RP, PS RP).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subject was diagnosed with NIDJD.
* Subject is a suitable candidate for cemented primary TKA using the devices described in the Clinical Investigation Plan (CIP)with either resurfaced or non-resurfaced patellae.
* Subject has given voluntary, written informed consent to participate in this clinical investigation and has authorized the transfer of his/her information to DePuy.
* Subject is currently not bedridden.
* Subject, in the opinion of the Clinical Investigator, is able to understand this clinical investigation and co-operate with investigational procedures.
* Subject must be comfortable with speaking, reading, and understanding questions and providing responses in an available translated language for the PROs in the CIP.
* The devices specified in this CIP were implanted.
Exclusion Criteria
* Contralateral knee has already been enrolled in this study.
* Subject had a contralateral amputation.
* Previous partial knee replacement (unicompartmental, bicompartmental or patellofemoral joint replacement), patellectomy, high tibial osteotomy or primary TKA in affected knee.
* Subject is currently experiencing radicular pain from the spine.
* Subject has participated in an IDE/IND clinical investigation with an investigational product in the last three months.
* Subject is currently involved in any personal injury litigation, medical-legal or worker's compensation claims.
* Subject is a known drug or alcohol abuser or has a psychological disorder that could affect their ability to complete patient reported questionnaires.
* Subject was diagnosed with fibromyalgia that is currently being treated with prescription medication.
* Subject has significant neurological or musculoskeletal disorders or disease that may adversely affect gait or weight bearing (e.g. muscular dystrophy, multiple sclerosis, Charcot disease).
* Subject is suffering from inflammatory arthritis (e.g. rheumatoid arthritis, juvenile rheumatoid arthritis, psoriatic arthritis, systemic lupus erythematosus, etc.).
* Subject is not comfortable with speaking, reading, and understanding questions and providing responses in an available translated language for the PROs in the CIP.
* Subject has a medical condition with less than 2 years of life expectancy.
22 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
DePuy Orthopaedics
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ahmad S, Ismail, MS, CCRP
Role: STUDY_DIRECTOR
DePuy Orthopaedics
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Orthopaedic Specialty Institute
Orange, California, United States
UCSD Medical Center
San Diego, California, United States
Orhopaedic Center of the Rockies
Fort Collins, Colorado, United States
The Arthroplasty Foundation
Louisville, Kentucky, United States
Hip and Knee Research of Nevada
Las Vegas, Nevada, United States
Dartmouth Medical School/Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, United States
Cardinal Orthopaedic Institute
Columbus, Ohio, United States
Anderson Orthopaedic Research Institute
Alexandria, Virginia, United States
Swedish Orthopedic Institute
Seattle, Washington, United States
Sutherland Hospital
Caringbah, New South Wales, Australia
Hornsby Ku-ring-gai Hospital
Hornsby, New South Wales, Australia
Wakefield Orthopaedic Clinic
Adelaide, South Australia, Australia
Freemantle Hospital
Crawley, Western Australia, Australia
Ascot Hospital
Auckland, , New Zealand
Queen Margaret Hospital
Dunfermline, Fife, United Kingdom
The Royal Surrey County Hospital
Guildford, Surrey, United Kingdom
Princess Alexandra Hospital
Harlow, , United Kingdom
University Hospital Llandough
Llandough, , United Kingdom
James Cook University Hospital
Middlesbrough, , United Kingdom
Clifton Park NHS Treatment Centre
York, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Hamilton WG, Brenkel IJ, Barnett SL, Allen PW, Dwyer KA, Lesko JP, Kantor SR, Clatworthy MG. Comparison of Existing and New Total Knee Arthroplasty Implant Systems From the Same Manufacturer: A Prospective, Multicenter Study. J Am Acad Orthop Surg Glob Res Rev. 2021 Dec 15;5(12):e21.00136. doi: 10.5435/JAAOSGlobal-D-21-00136.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
10004
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.